Invesaro

Stocks CDLR Financial statements

Financial statements

Cadeler A/S financial statements

Income statement, balance sheet and cash flow statement for the last 5 fiscal years, taken from the XBRL data Cadeler A/S files with the SEC in its annual reports.

In EUR millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2021FY2023FY2023FY2024FY2025
Revenue60.9106109249620
Cost of revenue38.949.559.9124237
Gross profit22.156.948.8125384
General and administrative10.915.734.557.174.6
Operating income11.141.214.469.4318
Interest expense5.499.684.497.237.4
Interest income1.84.031.545.237.5
Pre-tax income7.4435.511.567.5288
Income tax-0.0102.417.68
Net income7.4535.511.565.1280
EBITDA11.542.21572321
EPS, basic0.060.220.060.190.80
EPS, diluted0.060.220.060.190.79

Balance sheet

FY2021FY2023FY2023FY2024FY2025
Cash and equivalents2.311996.651.3152
Receivables19.518.230.663139
Inventory0.440.551.841.043.54
Total current assets24.659.5147181390
Property, plant and equipment3996061,0861,7122,937
Lease right-of-use assets0.460.290.9710.312.6
Total assets4256701,2531,9373,417
Accounts payable9.78.8232.643.698.2
Total current liabilities53.911.853.6124351
Lease liabilities0.210.399.712.5
Total liabilities99.51292947031,913
Total debt5,9721,696
Paid-in capital3395109531,0991,099
Retained earnings-32.83.11-7.3759.4342
Shareholders' equity3255419591,2341,504
Total equity3255419591,2341,504
Total liabilities and equity4256701,2531,9373,417

Cash flow statement

FY2021FY2023FY2023FY2024FY2025
Net income7.4535.511.565.1280
Depreciation and amortization0.411.020.532.523.55
Cash from operations30.22963.493.1394
Capital expenditures-163-225-66.9-616-1,236
Cash from investing-163-225-54.7-623-1,264
Debt issued1132003661,309
Debt repaid-10-65-115-10.6-279
Stock issued79.218301550
Share buybacks0-1.28-1.72
Cash from financing71.821370.3482968
Exchange rate effect-1.332.522.7
Net change in cash-61.316.778.9-47.997.7
Free cash flow-133-196-3.52-522-841
Income taxes paid-0.160.01-01.753.51

Key metrics

Worked out from the statements above. Latest values use fiscal 2025. No valuation: the share price is quoted in a different currency than the statements.

Profitability

MetricValueHow it is calculated
Gross margin61.8%Gross profit / revenue.
Operating margin51.2%Operating income / revenue.
EBITDA margin51.8%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin46.4%Pre-tax income / revenue.
Net margin45.2%Net income / revenue.
FCF margin-135.6%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin63.5%Cash from operations / revenue.
Effective tax rate2.7%Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)20.5%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)10.5%Net income / average total assets.
Return on invested capital (ROIC)6.1%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
Capex / revenue199.2%Capital expenditures / revenue.
D&A / revenue0.6%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y149.4%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y80.0%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit growth, 1y208.1%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y88.9%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income growth, 1y357.6%Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y97.6%Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA growth, 1y346.5%EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y96.7%Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income growth, 1y330.6%Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y99.0%Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS growth, 1y315.8%EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y53.1%Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow growth, 1y323.4%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y138.6%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value growth, 1y21.9%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y40.6%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets growth, 1y76.4%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y72.1%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.

Balance sheet health

MetricValueHow it is calculated
Current ratio1.11xCurrent assets / current liabilities.
Quick ratio0.83x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.43x(Cash + short-term investments) / current liabilities.
Debt / equity1.13xTotal debt / shareholders' equity. Not shown when equity is negative.
Debt / assets49.6%Total debt / total assets.
Liabilities / assets56.0%Total liabilities / total assets.
Net debt€1.54BTotal debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA4.81xNet debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage8.50xOperating income / interest expense.
Working capital€38.9MCurrent assets - current liabilities.
Tangible book value€1.50BShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.23xRevenue / average total assets.
Fixed asset turnover0.27xRevenue / average property, plant and equipment.
Inventory turnover103xCost of revenue / average inventory.
Days inventory4 days365 x average inventory / cost of revenue.
Receivables turnover6.14xRevenue / average receivables.
Days sales outstanding59 days365 x average receivables / revenue.
Days payables109 days365 x average accounts payable / cost of revenue.
Cash conversion cycle-46 daysDays inventory + days sales outstanding - days payables.
FCF conversion-300.3%Free cash flow / net income, when net income is positive.
Capex / operating cash flow313.5%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted€0.79Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic€0.80Net income per basic share, as reported (split-adjusted).
What was Cadeler A/S's revenue in fiscal 2025?

Cadeler A/S reported revenue of €620.4M for fiscal 2025, 149.4% higher than the year before.

Was Cadeler A/S profitable in fiscal 2025?

Yes. Net income was €280.2M, a net margin of 45.2%.

How much free cash flow did Cadeler A/S generate in fiscal 2025?

Cash from operations of €394.2M minus capital expenditures of €1.24B left free cash flow of -€841.5M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Cadeler A/S